Multiobjective optimization of fluphenazine nanocomposite formulation using NSGA-II method
The World Health Organization (WHO, 2019) reports that schizophrenia affects approximately 20 million people worldwide, and the annual number of new cases is estimated at 1.5%/10,000 people. As a result, there is a demand for making the relevant medicines work better. Using a fluphenazine (FZN) drug...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |